Press Release February 25, 2022Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Patients with Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma. 0 0 Share
Press Release February 25, 2022Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) plus Chemotherapy for First-Line Treatment of Patients with Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma with Tumor Cell PD-L1. 0 0 Share
Company Ticker News February 25, 2022Here's Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether 0 0 Share
General Market News February 25, 2022Stock Market Today: Dow Jones, S&P 500 Rebounds As Investors Assess The Russia-Ukraine Situation; Block (SQ) Stock Rises On Cash App Outlook 0 0 Share
Press Release February 19, 2022ZOOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Zoom Video Communications. 0 0 Share
General Market News February 18, 2022Homebuilders: 4 Reasons Margins Are Going To Get Squeezed 0 0 Share
Company Ticker News February 18, 2022Bristol Myers Squibb Is My Choice For A Dividend Growth Portfolio 0 0 Share
Press Release February 16, 2022Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes 0 0 Share
Press Release February 15, 2022Bristol Myers Squibb Announces Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion 0 0 Share